Trial intelligence / Profile preview

Dextromethorphan as Add-on Therapy in Rheumatoid Arthritis

NCT02368093Completed

Sponsor
Taichung Veterans General Hospital
Start
Jan 2010
Primary completion
Sep 2012
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of dextromethorphan in rheumatoid arthritis (RA), sponsored by Taichung Veterans General Hospital. Primary endpoint: Good European League Against Rheumatism Therapeutic Response Rate at 6 months. Started Jan 2010; status: completed.

02

Drugs

dextromethorphan
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT02368093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02368093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call